NASDAQ:PRXL - PAREXEL International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $88.08 0.00 (0.00 %) (As of 12/13/2018 04:00 PM ET)Previous Close$88.08Today's RangeN/A52-Week Range$51.16 - $88.10VolumeN/AAverage Volume1.04 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions. Receive PRXL News and Ratings via Email Sign-up to receive the latest news and ratings for PRXL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryLife Sciences Tools & Services SectorN/A Current SymbolNASDAQ:PRXL Previous Symbol CUSIP69946210 Webwww.parexel.com Phone+1-781-4879900 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees18,900 Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable PAREXEL International (NASDAQ:PRXL) Frequently Asked Questions What is PAREXEL International's stock symbol? PAREXEL International trades on the NASDAQ under the ticker symbol "PRXL." Has PAREXEL International been receiving favorable news coverage? News stories about PRXL stock have trended somewhat positive on Thursday, InfoTrie reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PAREXEL International earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. Who are PAREXEL International's key executives? PAREXEL International's management team includes the folowing people: Josef H. von Rickenbach, Chairman of the Board, Chief Executive OfficerMark A. Goldberg M.D., President, Chief Operating OfficerSimon Harford, Chief Financial Officer, Senior Vice President, Bio & Compensation - Xavier AB Flinois, President - PAREXEL InformaticsMichelle Graham, Chief Human Resource Officer, Senior Vice PresidentSybrand Pretorius M.D., Senior Vice President, Chief Scientific OfficerDouglas Alexander Batt, Senior Vice President, General Counsel, SecretaryRoland Andersson Ph.d., Senior Vice President - Clinical Research ServicesChristian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting, Bio & Compensation - David J. Godwin, Senior Vice President-Global Business How do I buy shares of PAREXEL International? Shares of PRXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PAREXEL International's stock price today? One share of PRXL stock can currently be purchased for approximately $88.08. What is PAREXEL International's official website? The official website for PAREXEL International is https://www.parexel.com/. How can I contact PAREXEL International? PAREXEL International's mailing address is 195 West St, WALTHAM, MA 02451-1111, United States. The medical research company can be reached via phone at +1-781-4879900. MarketBeat Community Rating for PAREXEL International (NASDAQ PRXL)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 363 (Vote Outperform)Underperform Votes: 493 (Vote Underperform)Total Votes: 856MarketBeat's community ratings are surveys of what our community members think about PAREXEL International and other stocks. Vote "Outperform" if you believe PRXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRXL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2018 by MarketBeat.com StaffFeatured Article: What are earnings reports?